Tentative Agenda

The following agenda is tentative and will be updated as we get closer to the event.

Day 1 | May 24, 2022

Time (ET)SessionParticipants/Speakers
12:00 PMWelcomeJohn Ngai, PhD
12:05 PMIntroduction and BackgroundSaskia Hendriks, MD, PhD
12:15 PMPanel 1: What needs may study participants have in relation to their trial participation, after a trial ends?Brandy Ellis
Jen French
Gabriel Lázaro-Muñoz, PhD, JD
James Mahoney, PhD
1:15 PMPanel 1 Discussion

Winston Chiong, MD, PhD
Nina Hsu, PhD

1:45 PMBreak 
2:30 PMPanel 2: What do different stakeholders currently provide, and what can/could they provide in terms of research-related care needs?Yagna Pathak, PhD
Martha Morrell, MD
Carl Li, MD, PhD
Shirley McCartney, PhD
Nick Langhals, PhD
Rhonda Robinson Beale, MD
4:00 PMPanel 2 DiscussionCo-Moderators:
Sameer Sheth, MD, PhD
Nina Hsu, PhD
4:45 PMDay 1 Wrap Up 
5:00 PMAdjourn 

Day 2 | May 25, 2022

Time (ET)SessionParticipants/Speakers
12:00 PMWelcomeJohn Ngai, PhD
12:05 PMRecap of Day 1Nina Hsu, PhD
12:30 PMPanel 3: What should be the minimum in research-related care that should be facilitated in implanted neural device trials? When would stakeholders have responsibilities to provide or facilitate more than the previously defined minimum? Tracy Dixon-Salazar, PhD
Patricio Riva Posse, MD
Sara Goering, PhD and Ishan Dasgupta, JD, MPH
Luann E. Van Campen, PhD, MA
John Marler, MD
1:45 PMPanel 3 DiscussionCo-Moderators:
Christine Grady, MSN, PhD
Saskia Hendriks, MD, PhD
2:30 PMBreak 
3:00 PMTown Hall with all Stakeholders
What are the gaps between what is currently facilitated and what is sufficient/appropriate? How can we best fill those gaps?
Hank Greely, JD
Saskia Hendriks, MD, PhD
4:30 PMDay 2 Wrap Up 
4:45 PMAdjourn